Who owns Zynerba Pharmaceuticals?
- CUSIP Number: 98986x109
Tip: Access positions for across all investors
Analyze quarterly positions in Zynerba Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Zynerba Pharmaceuticals stock
Who bought or sold Zynerba Pharmaceuticals this quarter?
There are no current stakeholders of Zynerba Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Zynerba Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Beryl Capital Management | Sep 2023 | 4.9M | $6.2M |
Highbridge Capital Management | Sep 2023 | 2.3M | $2.9M |
CSS | Sep 2023 | 482k | $615k |
Millennium Management | Sep 2023 | 325k | $413k |
Jane Street | Sep 2023 | 283k | $360k |
Crystalline Management | Sep 2023 | 231k | $294k |
Penserra Capital Management | Sep 2023 | 221k | $280k |
Hrt Financial | Sep 2023 | 203k | $258k |
PenderFund Capital Management | Sep 2023 | 123k | $213k |
Gts Securities | Sep 2023 | 120k | $153k |
Fifth Lane Capital | Sep 2023 | 100k | $127k |
Charles Schwab Investment Management | Sep 2023 | 38k | $48k |
Jpmorgan Chase & Co | Sep 2023 | 21k | $27k |
UBS Group | Sep 2023 | 20k | $26k |
Advisor Group Holdings | Sep 2023 | 16k | $21k |
King Wealth Management | Sep 2023 | 16k | $20k |
Virtu Financial | Sep 2023 | 13k | $17k |
National Asset Management | Sep 2023 | 13k | $16k |
Key FInancial | Sep 2023 | 7.5k | $9.6k |
Wells Fargo & Company | Sep 2023 | 2.5k | $3.1k |
Rhumbline Advisers | Sep 2023 | 805.00 | $1.0k |
Royal Bank of Canada | Sep 2023 | 315.00 | $0 |
Bank of America Corporation | Sep 2023 | 282.00 | $360.960000 |
Harbour Investments | Sep 2023 | 100.00 | $128.000000 |
Creative Planning | Sep 2023 | 100.00 | $128.000000 |